Eupraxia Pharmaceuticals Inc. EPRX

8.01 (0.15) (1.84%) as of 25 Sep
Market cap
$537.8M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22
Cash and Short Term Investments
80.56 33.10 19.34 18.26
Receivables
0.67 0.23 0.19 0.09
Total current assets
85.10 34.44 19.80 18.59
Property, Plant, Equpment (Net)
0.83 0.36 0.41 0.44
Long-term assets (Other)
0.06 0.08 0.01 0.00
Total non-current assets
1.05 0.51 0.46 0.53
Total Assets
86.15 34.94 20.27 19.12
Accounts Payable
5.55 3.03 3.92 2.93
Current Part of Debt
— — 10.40 0.08
Current Part of Capital Lease
0.08 0.07 0.05 0.05
Total current liabilities
5.63 3.10 19.37 3.06
Long Term Debt (Total)
0.08 — — 8.86
Total non-current liabilities
0.08 — — 8.86
Total liabilities
5.70 3.10 19.37 11.91
Additional Paid In Capital
28.52 20.50 17.51 16.85
Preferred Stock (Total)
29.74 31.71 — —
Common Stock (Net)
195.41 116.36 92.91 71.00
Retained Earnings
(169.58) (131.00) (105.50) (77.28)
Common Equity (Total)
50.71 0.13 0.89 7.21
Shareholders Equity (Total)
80.45 31.84 0.89 7.21
Shareholders Equity and Liabilities (Total)
86.15 34.94 20.27 19.12
Shares (Common)
51.94 35.64 27.28 21.59
Shareholders Equity (Tangible)
80.45 31.84 0.89 7.21
Net Debt
(80.49) (33.10) (8.94) (9.33)
Total Debt
0.08 — 10.40 8.94

Fold the line items

In millions of $ except per-share values · columns are period end dates